CLOV vs. LUMN

Last updated Jun 3, 2026

CLOV (Clover Health Investments, Corp.) and LUMN (Lumen Technologies, Inc.) are both stocks. CLOV operates in Healthcare Plans (Healthcare), while LUMN operates in Telecom Services (Communication Services). Over the past 5 years, CLOV returned -16.04%/yr vs -4.75%/yr for LUMN. At a 0.20 correlation, their price movements are largely independent.

Performance

CLOV vs. LUMN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Clover Health Investments, Corp. (CLOV) and Lumen Technologies, Inc. (LUMN). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CLOV achieves a 58.72% return, which is significantly higher than LUMN's 35.91% return.

CLOV

• 1D: -4.85%
• 1M: 37.64%
• YTD: 58.72%
• 6M: 49.80%
• 1Y: 17.67%
• 3Y*: 61.60%
• 5Y*: -16.04%
• 10Y*: —

LUMN

• 1D: -0.38%
• 1M: 13.30%
• YTD: 35.91%
• 6M: 15.54%
• 1Y: 174.29%
• 3Y*: 73.84%
• 5Y*: -4.75%
• 10Y*: -3.61%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CLOV vs. LUMN - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
CLOV Clover Health Investments, Corp.	58.72%	-25.40%	230.85%	2.43%	-75.01%	-77.82%	64.41%
LUMN Lumen Technologies, Inc.	35.91%	46.33%	190.16%	-64.94%	-55.48%	38.82%	1.26%

Correlation

The correlation between CLOV and LUMN is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.19
Correlation (3Y) Calculated over the trailing 3-year period	0.18
Correlation (5Y) Calculated over the trailing 5-year period	0.22
Correlation (All Time) Calculated using the full available price history since Jun 15, 2020	0.20

Fundamentals

Market Cap CLOV : $1.95B LUMN : $10.55B
EPS CLOV : -$0.11 LUMN : -$1.75
PS Ratio CLOV : 0.87 LUMN : 0.87
PB Ratio CLOV : 5.74 LUMN : 0.91
Total Revenue (TTM) CLOV : $2.21B LUMN : $12.12B
Gross Profit (TTM) CLOV : $939.14M LUMN : $1.52B
EBITDA (TTM) CLOV : -$55.21M LUMN : $1.12B

Return for Risk

CLOV vs. LUMN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CLOV

CLOV Risk / Return Rank: 49
CLOV Sharpe Ratio Rank: 50
CLOV Sortino Ratio Rank: 50
CLOV Omega Ratio Rank: 50
CLOV Calmar Ratio Rank: 48
CLOV Martin Ratio Rank: 47

LUMN

LUMN Risk / Return Rank: 85
LUMN Sharpe Ratio Rank: 89
LUMN Sortino Ratio Rank: 85
LUMN Omega Ratio Rank: 84
LUMN Calmar Ratio Rank: 85
LUMN Martin Ratio Rank: 80

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CLOV vs. LUMN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Clover Health Investments, Corp. (CLOV) and Lumen Technologies, Inc. (LUMN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CLOV	LUMN	Difference
Sharpe ratio Return per unit of total volatility	0.26	2.20	-1.94
Sortino ratio Return per unit of downside risk	0.88	2.73	-1.84
Omega ratio Gain probability vs. loss probability	1.11	1.35	-0.24
Calmar ratio Return relative to maximum drawdown	0.34	3.58	-3.24
Martin ratio Return relative to average drawdown	0.62	6.90	-6.28
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CLOV vs. LUMN - Sharpe Ratio Comparison

The current CLOV Sharpe Ratio is 0.26, which is lower than the LUMN Sharpe Ratio of 2.20. The chart below compares the historical Sharpe Ratios of CLOV and LUMN, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	CLOV	LUMN	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.26	2.20	-1.94
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.18	-0.06	-0.13
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.05	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.18	0.18	-0.37

Drawdowns

CLOV vs. LUMN - Drawdown Comparison

The maximum CLOV drawdown since its inception was -97.19%, roughly equal to the maximum LUMN drawdown of -95.26%. Use the drawdown chart below to compare losses from any high point for CLOV and LUMN.

Drawdown Indicators

	CLOV	LUMN	Difference
Max Drawdown Largest peak-to-trough decline	-97.19%	-95.26%	-1.93%
Max Drawdown (1Y) Largest decline over 1 year	-55.50%	-47.34%	-8.16%
Max Drawdown (3Y) Largest decline over 3 years	-64.73%	-69.66%	+4.93%
Max Drawdown (5Y) Largest decline over 5 years	-97.19%	-92.86%	-4.33%
Max Drawdown (10Y) Largest decline over 10 years	—	-94.44%	—
Current Drawdown Current decline from peak	-83.16%	-48.91%	-34.25%
Average Drawdown Average peak-to-trough decline	-76.62%	-27.64%	-48.98%
Ulcer Index Depth and duration of drawdowns from previous peaks	30.54%	24.56%	+5.98%

Volatility

CLOV vs. LUMN - Volatility Comparison

The current volatility for Clover Health Investments, Corp. (CLOV) is 22.50%, while Lumen Technologies, Inc. (LUMN) has a volatility of 25.19%. This indicates that CLOV experiences smaller price fluctuations and is considered to be less risky than LUMN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CLOV	LUMN	Difference
Volatility (1M) Calculated over the trailing 1-month period	22.50%	25.19%	-2.69%
Volatility (6M) Calculated over the trailing 6-month period	39.35%	57.47%	-18.12%
Volatility (1Y) Calculated over the trailing 1-year period	68.61%	79.78%	-11.17%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	88.12%	85.14%	+2.98%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	85.66%	67.50%	+18.16%

Dividends

CLOV vs. LUMN - Dividend Comparison

Neither CLOV nor LUMN has paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CLOV Clover Health Investments, Corp.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
LUMN Lumen Technologies, Inc.	0.00%	0.00%	0.00%	0.00%	14.37%	7.97%	10.26%	7.57%	14.26%	12.95%	9.08%	8.59%

Financials

CLOV vs. LUMN - Profitability Comparison

The chart below illustrates the profitability comparison between Clover Health Investments, Corp. and Lumen Technologies, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

CLOV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Clover Health Investments, Corp. reported a gross profit of 692.13M and revenue of 749.19M. Therefore, the gross margin over that period was 92.4%.

LUMN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Lumen Technologies, Inc. reported a gross profit of 0.00 and revenue of 2.90B. Therefore, the gross margin over that period was 0.0%.

CLOV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Clover Health Investments, Corp. reported an operating income of 27.33M and revenue of 749.19M, resulting in an operating margin of 3.7%.

LUMN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Lumen Technologies, Inc. reported an operating income of 602.00M and revenue of 2.90B, resulting in an operating margin of 20.8%.

CLOV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Clover Health Investments, Corp. reported a net income of 27.33M and revenue of 749.19M, resulting in a net margin of 3.7%.

LUMN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Lumen Technologies, Inc. reported a net income of -200.00M and revenue of 2.90B, resulting in a net margin of -6.9%.

Frequently Asked Questions

Can I hold both CLOV and LUMN in my portfolio?

CLOV and LUMN have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CLOV or LUMN?

LUMN has higher volatility (25.19%) compared to CLOV (22.50%). In terms of maximum drawdown, CLOV dropped -97.19% vs LUMN's -95.26%.

Which has better risk-adjusted returns?

LUMN currently has the higher Sharpe Ratio (2.20 vs 0.26), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.